The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2022 | The interplay between genetic and environmental factors in MBL
Andreas Agathangelidis, PhD, Center for Research and Technology Hellas, Thermi, Greece, discusses the features of monoclonal B-cell lymphocytosis (MBL) and its cytogenetic resemblance to chronic lymphocytic leukemia (CLL). The observation that not all cases of MBL will evolve into CLL has provided clues as to the role of environmental factors, as well as the characteristic B-cell receptor properties in each disease. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
